JUL 23, 2026 · JOURNAL ARTICLE
Metabolic plasticity underlies ferroptosis resistance driven by mutant p53 in pancreatic ductal adenocarcinoma
Molecular Cancer
Mechanistic study in cell and animal models demonstrating mutant p53-driven ferroptosis resistance and a potential combination therapeutic approach, but lacks clinical trial data and hard patient outcomes.
Study details
DesignPreclinical mechanistic study combining iso…
InterventionFerroptosis inducers; pharmacological react…
ComparatorTP53-knockout cells versus mutant TP53-expr…